Who owns the MRNA LIGHTNING trademark?

The MRNA LIGHTNING trademark is owned by Anima Biotech Inc..

What is the serial number for MRNA LIGHTNING?

The USPTO serial number for MRNA LIGHTNING is 79347337.

What is the registration number for MRNA LIGHTNING?

MRNA LIGHTNING is registered under USPTO registration number 7403950.

MRN

USPTO Trademark Record

REGISTERED

MRNA LIGHTNING

Q: What class is the MRNA LIGHTNING trademark registered in?

The MRNA LIGHTNING trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79347337·Reg 7403950·Filed May 25, 2022

Owner Anima Biotech Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MRNA LIGHTNING (Serial No. 79347337), Registration No. 7403950, is a registered US trademark filed on May 25, 2022 by Anima Biotech Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: June 04, 2030

Mark Intelligence

MRNA LIGHTNING (Reg. #7403950) is a registered US trademark that has been protecting its owner, Anima Biotech Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

May 25, 2022

SERIAL

79347337

REG#

7403950

REGISTERED

Jun 04, 2024

Owner

Applicant

Anima Biotech Inc.

Entity

Corporation

State

Address

75 Claremont Rd, Ste 102, Bernardsville NJ 07924

Country

Attorney

NameJonathan D. Reichman, Esq.

Law firm

Jonathan D. Reichman, Esq. Hunton Andrews Kurth LLP

Address

200 PARK AVENUE, New York, NY 10166, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 25, 2022

Serial Number79347337

Registration No.7403950

Registration DateJun 04, 2024

Status DateJun 04, 2024

Published for OppositionMar 19, 2024

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

35 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 30, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Nov 14, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Nov 14, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Sep 04, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jun 04, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 04, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Mar 19, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 19, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 28, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 28, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 10, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Feb 05, 2024

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 24, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 24, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Jan 23, 2024

ASSIGNED TO LIE

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jan 17, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jan 17, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

REFUSAL PROCESSED BY IB

Oct 04, 2023

REFUSAL PROCESSED BY IB

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 05, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Aug 30, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 30, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 30, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 27, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 26, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 26, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

May 24, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 04, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 04, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 16, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Mar 15, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 14, 2023

ASSIGNED TO EXAMINER

NEW REPRESENTATIVE AT IB RECEIVED

Mar 04, 2023

NEW REPRESENTATIVE AT IB RECEIVED

APPLICATION FILING RECEIPT MAILED

Aug 16, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 12, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 11, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

MRNA LIGHTNING

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Anima Biotech Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jonathan D. Reichman, Esq.

Resources

Company